cfTrack: Exome-wide mutation analysis of cell-free DNA to simultaneously monitor the full spectrum of cancer treatment outcomes: MRD, recurrence, and evolution

Article Information

doi

History

¹Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA
²Bioinformatics Interdepartmental Graduate Program, University of California at Los Angeles, Los Angeles, CA 90095, USA
³EarlyDiagnostics Inc. ,Los Angeles, CA 90095, USA
⁴Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
⁵Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
⁶UCLA Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, 90095, USA
⁷UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Los Angeles, CA, 90095, USA
⁸Molecular Biology Institute, University of California Los Angeles, Los Angeles, CA, 90095, USA
⁹Department of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, 90095, California, USA
¹⁰Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, 90095, California, USA
¹¹VA Greater Los Angeles Health Care System, Los Angeles, California, 90073, USA
¹²Department of Microbiology, Immunology and Molecular Genetics, University of California at Los Angeles, Los Angeles, CA 90095, USA

↵*Correspondence Author:
Xianghong Jasmine Zhou. Mail address: 630 Charles E Young Dr S, Suite 33-251, Los Angeles, CA 90095; Phone: 310-267-0363; Email: XJZhou{at}mednet.ucla.edu.